Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 105

1.

Levofloxacin prophylaxis in patients with myeloma.

Teh BW, Harrison SJ, Worth LJ, Thursky KA, Slavin MA.

Lancet Oncol. 2020 Feb;21(2):e67. doi: 10.1016/S1470-2045(19)30824-1. No abstract available.

PMID:
32007198
2.

Risk stratification in children with cancer and febrile neutropenia: A national, prospective, multicentre validation of nine clinical decision rules.

Haeusler GM, Thursky KA, Slavin MA, Babl FE, De Abreu Lourenco R, Allaway Z, Mechinaud F, Phillips R; Australian PICNICC study group and the PREDICT network.

EClinicalMedicine. 2020 Jan 7;18:100220. doi: 10.1016/j.eclinm.2019.11.013. eCollection 2020 Jan.

3.

Epidemiology and risks for infection following cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy.

Smibert OC, Slavin MA, Teh B, Heriot AG, Penno J, Ismail H, Thursky KA, Worth LJ.

Support Care Cancer. 2019 Nov 12. doi: 10.1007/s00520-019-05093-5. [Epub ahead of print]

PMID:
31712951
4.

Antibiotic appropriateness and guideline adherence in hospitalized children: results of a nationwide study.

McMullan BJ, Hall L, James R, Mostaghim M, Jones CA, Konecny P, Blyth CC, Thursky KA.

J Antimicrob Chemother. 2020 Mar 1;75(3):738-746. doi: 10.1093/jac/dkz474.

PMID:
31697335
5.

Beta-Lactam and Sulfonamide Allergy Testing Should Be a Standard of Care in Immunocompromised Hosts.

Trubiano JA, Slavin MA, Thursky KA, Grayson ML, Phillips EJ.

J Allergy Clin Immunol Pract. 2019 Sep - Oct;7(7):2151-2153. doi: 10.1016/j.jaip.2019.05.051. Epub 2019 Jun 13.

6.

Microbiome transplantation and modulation of immune related adverse events.

Smibert OC, Guo CW, Khoo C, Thursky KA, Sandhu S, Slavin MA.

EClinicalMedicine. 2019 Mar 12;8:10-11. doi: 10.1016/j.eclinm.2019.03.003. eCollection 2019 Feb. No abstract available.

7.

FDG-PET/CT in managing infection in patients with hematological malignancy: clinician knowledge and experience in Australia.

Douglas AP, Thursky KA, Worth LJ, Harrison SJ, Hicks RJ, Slavin MA.

Leuk Lymphoma. 2019 Oct;60(10):2471-2476. doi: 10.1080/10428194.2019.1590571. Epub 2019 Apr 5.

PMID:
30947578
8.

Skin and soft tissue infections and current antimicrobial prescribing practices in Australian aged care residents.

Bennett NJ, Imam N, Ingram RJ, James RS, Buising KL, Bull AL, Chen CS, Thursky KA, Worth LJ.

Epidemiol Infect. 2019 Jan;147:e87. doi: 10.1017/S0950268819000128.

9.

Better Sepsis Management Rather Than Fluoroquinolone Prophylaxis for Patients With Cancer-Related Immunosuppression.

Slavin MA, Worth LJ, Seymour JF, Thursky KA.

J Clin Oncol. 2019 May 1;37(13):1139-1140. doi: 10.1200/JCO.18.01474. Epub 2019 Mar 7. No abstract available.

PMID:
30844318
10.

Impact of a hospital-wide sepsis pathway on improved quality of care and clinical outcomes in surgical patients at a comprehensive cancer centre.

Hiong A, Thursky KA, Venn G, Teh BW, Haeusler GM, Crane M, Slavin MA, Worth LJ.

Eur J Cancer Care (Engl). 2019 May;28(3):e13018. doi: 10.1111/ecc.13018. Epub 2019 Feb 13.

PMID:
30761632
11.

Nonneutropenic fever in children with cancer: A scoping review of management and outcome.

Allaway Z, Phillips RS, Thursky KA, Haeusler GM.

Pediatr Blood Cancer. 2019 Jun;66(6):e27634. doi: 10.1002/pbc.27634. Epub 2019 Feb 5. Review.

12.

High rates of proven invasive fungal disease with the use of ibrutinib monotherapy for relapsed or refractory chronic lymphocytic leukemia.

Teh BW, Chui W, Handunnetti S, Tam C, Worth LJ, Thursky KA, Slavin MA.

Leuk Lymphoma. 2019 Jun;60(6):1572-1575. doi: 10.1080/10428194.2018.1543884. Epub 2019 Jan 11. No abstract available.

PMID:
30632838
13.
14.

Antibiotic allergy testing improves antibiotic appropriateness in patients with cancer.

Trubiano JA, Grayson ML, Phillips EJ, Stewardson AJ, Thursky KA, Slavin MA.

J Antimicrob Chemother. 2018 Nov 1;73(11):3209-3211. doi: 10.1093/jac/dky307. No abstract available.

15.

How antibiotic allergy labels may be harming our most vulnerable patients.

Trubiano JA, Grayson ML, Thursky KA, Phillips EJ, Slavin MA.

Med J Aust. 2018 Jun 18;208(11):469-470. No abstract available.

16.

FDG PET/CT imaging in detecting and guiding management of invasive fungal infections: a retrospective comparison to conventional CT imaging.

Douglas AP, Thursky KA, Worth LJ, Drummond E, Hogg A, Hicks RJ, Slavin MA.

Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):166-173. doi: 10.1007/s00259-018-4062-8. Epub 2018 Jun 7.

PMID:
29882160
17.

Meeting the challenge for effective antimicrobial stewardship programs in regional, rural and remote hospitals - what can we learn from the published literature?

Bishop J, Kong DC, Schulz TR, Thursky KA, Buising KL.

Rural Remote Health. 2018 May;18(2):4442. doi: 10.22605/RRH4442. Epub 2018 May 24. Review.

18.

Management of fever and neutropenia in children with cancer: A survey of Australian and New Zealand practice.

Haeusler GM, Slavin MA, Bryant PA, Babl FE, Mechinaud F, Thursky KA.

J Paediatr Child Health. 2018 Jul;54(7):761-769. doi: 10.1111/jpc.13899. Epub 2018 Apr 14.

PMID:
29655245
19.

The Combined Utility of Ex Vivo IFN-γ Release Enzyme-Linked ImmunoSpot Assay and In Vivo Skin Testing in Patients with Antibiotic-Associated Severe Cutaneous Adverse Reactions.

Trubiano JA, Strautins K, Redwood AJ, Pavlos R, Konvinse KC, Aung AK, Slavin MA, Thursky KA, Grayson ML, Phillips EJ.

J Allergy Clin Immunol Pract. 2018 Jul - Aug;6(4):1287-1296.e1. doi: 10.1016/j.jaip.2017.09.004. Epub 2017 Oct 31.

20.

Supplemental Content

Loading ...
Support Center